Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen for bleeding reduction in lumbar surgery
IRCT20180811040763N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fibrinogen human in lumbosacral disc disease (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Serum fibrinogen level, Partial thromboplastin time and 3 more. Started Aug 2018; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on IRCT20180811040763N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180811040763N1.